US Stocks
/
Citius Oncology, Inc. Share Price
Citius Oncology, Inc. Share Price

Citius Oncology, Inc. Share Price

NASDAQ: CTOR | Micro Cap
$0.85
-$0.00 (-0.07%) Last updated on 07 Oct, 2026 | 19:02 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Citius Oncology, Inc. Stock Performance

Open
$0.85
Prev. Close
$0.85
Circuit Range
N/A
Day Range
$0.85 - $0.85
Year Range
$0.49 - $2.17
Volume
100
Average Traded
$0.85

Citius Oncology, Inc. Share Price Today

As of 8 October 2026, Citius Oncology, Inc.'s share price is $0.85. The stock opened at $0.85, compared to its previous close of $0.85. During today's trading session, Citius Oncology, Inc.'s share price traded between $0.85 and $0.85, with an average price of $0.85. Over the past 52 weeks, the stock has recorded a high of $2.17 and a low of $0.49. In terms of performance, Citius Oncology, Inc.'s share price has declined by 4.48% over the last six months and is down 49.70% on a year-on-year basis.

Citius Oncology, Inc. Share Price Chart

$0.85$0.85
L
Show Current Price
H

Citius Oncology, Inc. Stock Fundamentals & Key Indicators

Market Cap
$62.29M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.44
Revenue (TTM)
$0.00
Return On Equity (TTM)
-114.06%
Profit Margin
N/A
Debt to Equity
0.16
Quarterly Earnings Growth YoY
-78.40%

Citius Oncology, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$3.94$1.67$1.49
Net Profit-$5.00-$5.53-$26.61-$8.92
Net Profit MarginN/A-140.36%-1593.41%-598.66%
Income ChangeN/A-10.60%-381.19%66.48%

Citius Oncology, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$21.15-$24.76
Net Profit MarginN/AN/A
Income ChangeN/A-17.07%

About Citius Oncology, Inc.

Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.

Citius Oncology, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.07
$0.85
-16.67%
Sep 2026
$0.74
$1.02
+34.21%
Aug 2026
$0.68
$0.76
+37.18%
Jul 2026
$0.71
$0.55
-18.77%
Jun 2026
$0.79
$0.68
-15.80%
May 2026
$0.89
$0.81
-8.99%
Apr 2026
$0.61
$0.89
+43.78%
Mar 2026
$1.08
$0.62
-42.95%
Feb 2026
$1.04
$1.08
+0.46%
Jan 2026
$1.01
$1.08
+10.32%
Dec 2025
$1.48
$0.98
-27.48%
Nov 2025
$1.73
$1.35
-20.12%

CTOR Share Price FAQs

What is Citius Oncology, Inc. share price today?

chevron-up
Citius Oncology, Inc. share price today is $0.85 as on October 7, 2026 at 7:02 pm IST.

What is the 52 week high and 52 week low of Citius Oncology, Inc. stock?

chevron-up
The 52 week high of Citius Oncology, Inc. stock is $2.17, while the 52 week low is $0.49 as of 7 Oct '26.

What is CTOR's market capitalisation today?

chevron-up
CTOR market capitalisation is $62.29M as of October 8, 2026, at 4:07 pm IST.

What is CTOR's net income for the last quarter?

chevron-up
CTOR's net income for the last quarter is -8.92B USD.

What is the 5 year returns of CTOR?

chevron-up
The 5 year returns of CTOR is -91.62% as on 7 Oct '26.

What is the high & low stock price of CTOR today?

chevron-up
CTOR stock price hit a high of $0.85 and low of $0.85 as of 7 Oct '26.

Can I buy CTOR shares in India?

chevron-up
Yes. You can buy CTOR in India by opening an international trading account.